Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Most stocks end up losing you money. What's an investor to do?
11:01am, Friday, 19'th May 2023
If you're going to try to retire early and rich by picking the right stocks, there's something you should know first.
7 Upcoming Dividend Increases, Including 1 Dividend King
03:50pm, Thursday, 18'th May 2023
All these stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 10.8% and a median increase of 8.1%.
2 Dividend Stocks to Double Up On Right Now
08:35am, Wednesday, 17'th May 2023
Falling share prices have pushed up the dividend yields on several high-quality companies. Johnson & Johnson currently yields around 3%.
Which Pharmaceuticals Stock Is A Better Pick: Johnson & Johnson Or Eliquis' Maker?
08:00am, Wednesday, 17'th May 2023
There is more to the comparison, and in the sections below, we discuss why we believe BMY stock will offer higher returns than JNJ stock in the next three years.
3 No-Brainer Stocks to Buy With $1,000 Right Now
05:21am, Wednesday, 17'th May 2023
Stock market corrections, while temporarily unpleasant, are blessings in disguise for opportunistic investors. These three inexpensive industry leaders have the competitive edges necessary to deliver
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
05:10am, Wednesday, 17'th May 2023
Johnson & Johnson, Paychex, and Keurig Dr Pepper are all solid dividend stocks with above-average yields. These businesses should perform well this year and beyond.
Don't Panic. 3 Defensive Stocks to Diversify Into ASAP
05:53pm, Tuesday, 16'th May 2023
Investors seeking to preserve their capital are increasingly turning to defensive stocks amidst the volatility. These stocks have defensive qualities and the potential to grow dividends, supported by
Top 5 Buys of Paul Tudor Jones' Firm in the 1st Quarter
05:19pm, Tuesday, 16'th May 2023
Paul Tudor Jones (Trades, Portfolio), founder and chief investment officer of Boston-based Tudor Investment Group, disclosed in a regulatory filing that his firm's top buys during the first quarter in
J&J's proposed talc settlement would pay $400 million to US state AGs
11:58am, Tuesday, 16'th May 2023
Johnson & Johnson has set aside $400 million to resolve U.S. state consumer protection actions as part of its broader $8.9 billion effort to settle claims that its Baby Powder and other talc products
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
10:39am, Tuesday, 16'th May 2023
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?
09:10am, Tuesday, 16'th May 2023
Johnson & Johnson is a Dividend King that has increased its dividend for 61 consecutive years. UnitedHealth Group should benefit from the growth of Medicare Advantage.
Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks
03:30pm, Sunday, 14'th May 2023
Warren Buffett is credited with saying that his preferred length of time for owning a stock is forever. To give credit where credit is due, the Oracle of Omaha does put his money where his mouth is.
3 Bargain Dividend Stocks to Boost Your Passive Income
03:16pm, Sunday, 14'th May 2023
In good times and bad, investors want the best dividend stocks for passive income. However, it's more than just Googling the top dividend names or biggest yields.
2 No-Brainer Healthcare Stocks to Buy Right Now
08:55am, Saturday, 13'th May 2023
Down slightly to start the year, investors may want to capitalize on these steady operators. Powered by high returns on invested capital, these two stocks are excellent compounders.
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997
12:55pm, Friday, 12'th May 2023
Eli Lilly & Co. was on track Friday to close with a greater market capitalization than Johnson & Johnson for the first time since October 1997, according to Dow Jones Market Data.
